Grants

Summary

Fiscal Year (time period)Grants nameIssuing authorityContents/Themes
FY2015
(Apr. 1/2016-Feb. 28/2017)
FY2015 “Research and Development Venture Support Project / Entrepreneur Candidate (Start-up Innovator)”New Energy and Industrial Technology Development Organization (NEDO)Development of cellular medicines using novel human neural stem cells
FY2018
(Oct. 10/2017-Feb. 28/2018)
FY2018 “Research and Development Venture Support Project / Commercialization Support for R&D Ventures in Seed Phase”New Energy and Industrial Technology Development Organization (NEDO)Development of regenerative medicine products using “OligoGenie” human neural stem cells
FY2019
(Dec. 10/2019-Feb. 9/2020)
FY2019 Project to Promote “Corporate Forest/University-Industry Forest” (Business Promotion Course)KYOTO Industrial Support Organization 21Research and development of GMP production of OligoGenie cells for clinical use
FY2021
(Jun. 28/2021-Feb. 28/2022)
FY2021 “Startups Solving Social Issues”Advanced Science, Technology & Management Research Institute of KYOTO (ASTEM)Establishment of a Master Cell Bank Production Method for Human Neural Stem Cells for Clinical Trials
FY2021
(Sep. 1/2021-Aug. 31/2022)
FY2021 “Next Generation Regional Industry Promotion Project”KYOTO Industrial Support Organization 21Efficacy of human neural stem cell “OligoGenie” in the treatment of Alzheimer’s disease.
FY2024
(Oct. 20/2023-Jan. 31/2024)
FY2024 “Small and Medium Enterprise Management Reform Support Project”
KYOTO Industrial Support Organization 21Development of oligodendrocyte progenitor cells and culture media for commercial research
FY2024
(Nov. 27/2023-Sep. 31/2024)
The 13th public offering of “Subsidy for Sustaining Small Businesses”Central Federation of Societies of Commerce and IndustryDevelopment of exosome formulation for out-licensing to pharmaceutical companies
FY2025
(Sep. 29/2024-Jan. 31/2025)
FY2025 “Kyoto Economic Gardening Support and Enhancement Project”KYOTO Industrial Support Organization 21Efficacy of Human Neural Stem Cells “OligoGenie” in the Treatment of Multiple Sclerosis